Literature DB >> 8376988

Low selenium diet affects monoamine turnover differentially in substantia nigra and striatum.

A Castaño1, J Cano, A Machado.   

Abstract

Turnover of dopamine, noradrenaline, serotonin, and their metabolites has been measured in striatum and substantia nigra of adult female rats that were fed control or selenium-deficient diets for 15 days. In addition, the glutathione peroxidase activity has been studied. The most striking result was the increase of dopamine turnover (63%) and 3-methoxytyramine turnover (55%) in substantia nigra between control and experimental animals. On the other hand, no changes were found in the turnover rate of dopamine and its metabolites in the striatum. Likewise, no changes were found in noradrenaline turnover in substantia nigra. In the striatum, there was a significant increase of serotonin turnover versus no change for 5-hydroxy-3-indoleacetic acid. However, in the substantia nigra, serotonin turnover did not show significant changes, whereas 5-hydroxy-3-indoleacetic acid turnover decreased. At the same time, glutathione peroxidase activity significantly decreased in both structures after selenium-deficient diets. These results suggest that a selenium-deficient diet for a short period of time decreases brain protection, principally in the substantia nigra, against oxidative damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376988     DOI: 10.1111/j.1471-4159.1993.tb13622.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

1.  Uptake of 75-Selenium into the central nervous system of the rat.

Authors:  R G Pullen; M Schofield; A Markham; J Lough; K Menton
Journal:  Neurochem Res       Date:  1995-10       Impact factor: 3.996

2.  Selenium exposure and depressive symptoms: the Coronary Artery Risk Development in Young Adults Trace Element Study.

Authors:  Laura A Colangelo; Ka He; Mary A Whooley; Martha L Daviglus; Steven Morris; Kiang Liu
Journal:  Neurotoxicology       Date:  2014-02-20       Impact factor: 4.398

3.  Cd2+, Mn2+, Ni2+ and Se2+ toxicity to Saccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2.

Authors:  Karyn Schmidt; Devin M Wolfe; Barbara Stiller; David A Pearce
Journal:  Biochem Biophys Res Commun       Date:  2009-04-05       Impact factor: 3.575

4.  Classical maple syrup urine disease and brain development: principles of management and formula design.

Authors:  Kevin A Strauss; Bridget Wardley; Donna Robinson; Christine Hendrickson; Nicholas L Rider; Erik G Puffenberger; Diana Shellmer; Diana Shelmer; Ann B Moser; D Holmes Morton
Journal:  Mol Genet Metab       Date:  2010-01-12       Impact factor: 4.797

5.  Sex-specific transcriptional responses of the zebrafish (Danio rerio) brain selenoproteome to acute sodium selenite supplementation.

Authors:  Maia J Benner; Matt L Settles; Gordon K Murdoch; Ronald W Hardy; Barrie D Robison
Journal:  Physiol Genomics       Date:  2013-06-04       Impact factor: 3.107

6.  Protection of the aged substantia nigra of the rat against oxidative damage by (-)-deprenyl.

Authors:  C P de la Cruz; E Revilla; V Steffen; J A Rodríguez-Gómez; J Cano; A Machado
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

7.  Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.

Authors:  Duy-Khanh Dang; Eun-Joo Shin; Dae-Joong Kim; Hai-Quyen Tran; Ji Hoon Jeong; Choon-Gon Jang; Seung-Yeol Nah; Jung Hwan Jeong; Jae Kyung Byun; Sung Kwon Ko; Guoying Bing; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  J Neuroinflammation       Date:  2018-02-21       Impact factor: 8.322

8.  Selenoprotein P Modulates Methamphetamine Enhancement of Vesicular Dopamine Release in Mouse Nucleus Accumbens Via Dopamine D2 Receptors.

Authors:  Daniel J Torres; Jordan T Yorgason; Catherine C Mitchell; Ayaka Hagiwara; Marilou A Andres; Suguru Kurokawa; Scott C Steffensen; Frederick P Bellinger
Journal:  Front Neurosci       Date:  2021-04-13       Impact factor: 4.677

Review 9.  Selenium in the Therapy of Neurological Diseases. Where is it Going?

Authors:  Agnieszka Dominiak; Anna Wilkaniec; Piotr Wroczyński; Agata Adamczyk
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Nutritional regulation of glutathione in stroke.

Authors:  P G Paterson; B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.